502
12. Debbab A, Aly AH, Lin WH, Proksch P. Bioactive compounds from marine bacteria and fungi.
Microb Biotechnol. 2010;3(5):544–63.
13. Maharaj R. Effects of abiotic stress (UV-C) induced activation of phytochemicals on the postharvest quality of horticultural crops. In: Phytochemicals - Isolation, Characterisation and
Role in Human Health. London: Intechopen; 2015. p. 221–44.
14. Bergman Å, Heindel JJ, Jobling S, Kidd K, Zoeller TR, Organization WH. State of the science
of endocrine disrupting chemicals 2012. World Health Organization; 2013.
15. Chemicals U. Ridding the world of POPs: A guide to the Stockholm convention on persistent
organic pollutants, the secretariat of the Stockholm convention and UNEP’s information unit
for conventions. April; 2005.
16. Qing Li Q, Loganath A, Seng Chong Y, Tan J, Philip Obbard J. Persistent organic pollutants
and adverse health effects in humans. J Toxicol Environ Health. 2006;69(21):1987–2005.
17. Grün F, Blumberg B. Environmental obesogens: organotins and endocrine disruption via
nuclear receptor signaling. Endocrinology. 2006;147(6):s50–s5.
18. Köhrle J. Environment and endocrinology: the case of thyroidology. Ann Endocrinol.
2008;69(2):116–22.
19. Hofmann PJ, Schomburg L, Köhrle J. Interference of endocrine disrupters with thyroid hormone receptor–dependent transactivation. Toxicol Sci. 2009;110(1):125–37.
20. George M, Ramesh N, Gopal S, Mohan V, Fathima FN. Diabetes and hypertension--A comprehensive assessment among workers in selected tea plantations, South India. Int J Med Sci
Public Health. 2018;7(12):1005–11.
21. Pestana D, Faria G, Sá C, Fernandes VC, Teixeira D, Norberto S, et al. Persistent organic pollutant levels in human visceral and subcutaneous adipose tissue in obese individuals—Depot
differences and dysmetabolism implications. Environ Res. 2014;133:170–7.
22. Soriano S, Alonso-Magdalena P, García-Arévalo M, Novials A, Muhammed SJ, Salehi A,
et al. Rapid insulinotropic action of low doses of bisphenol-A on mouse and human islets of
Langerhans: role of estrogen receptor β. PLoS One. 2012;7(2):e31109.
23. Batista TM, Alonso-Magdalena P, Vieira E, Amaral MEC, Cederroth CR, Nef S, et al. Shortterm treatment with bisphenol-A leads to metabolic abnormalities in adult male mice. PLoS
One. 2012;7(3):e33814.
24. Gothai S, Ganesan P, Park S-Y, Fakurazi S, Choi D-K, Arulselvan PJN. Natural phytobioactive compounds for the treatment of type 2 diabetes: inflammation as a target. Nutrients.
2016;8(8):461.
25. McAnany B, Martirosyan D. The effects of bioactive compounds on Alzheimer’s disease and
mild cognitive impairment. Funct Foods Health Dis. 2016;6(6):329–43.
26. Granzotto A, Zatta P. Resveratrol and Alzheimer’s disease: message in a bottle on red wine and
cognition. Front Aging Neurosci. 2014;6:95.
27. Vetterli L, Brun T, Giovannoni L, Bosco D, Maechler P. Resveratrol potentiates glucosestimulated insulin secretion in INS-1E β-cells and human islets through a SIRT1-dependent
mechanism. J Biol Chem. 2011;286(8):6049–60.
28. Eid HM, Nachar A, Thong F, Sweeney G, Haddad PS. The molecular basis of the antidiabetic action of quercetin in cultured skeletal muscle cells and hepatocytes. Pharmacogn Mag.
2015;11(41):74.
29. Youl E, Bardy G, Magous R, Cros G, Sejalon F, Virsolvy A, et al. Quercetin potentiates insulin
secretion and protects INS-1 pancreatic β-cells against oxidative damage via the ERK1/2 pathway. Br J Pharmacol. 2010;161(4):799–814.
30. Peng J, Li Q, Li K, Zhu L, Lin X, Lin X, et al. Quercetin improves glucose and lipid metabolism
of diabetic rats: involvement of Akt signaling and SIRT1. J Diabetes Res. 2017;2017:3417306.
31. Nijveldt RJ, Van Nood E, Van Hoorn DE, Boelens PG, Van Norren K, Van Leeuwen
PA. Flavonoids: a review of probable mechanisms of action and potential applications. Am J
Clin Nutr. 2001;74(4):418–25.
32. Oh YS, Jun H-SJN. Role of bioactive food components in diabetes prevention: effects on Betacell function and preservation. Nutr Metab Insights. 2014;7:51–9.
T. H. Mallhi et al.
12. Debbab A, Aly AH, Lin WH, Proksch P. Bioactive compounds from marine bacteria and fungi.
Microb Biotechnol. 2010;3(5):544–63.
13. Maharaj R. Effects of abiotic stress (UV-C) induced activation of phytochemicals on the postharvest quality of horticultural crops. In: Phytochemicals - Isolation, Characterisation and
Role in Human Health. London: Intechopen; 2015. p. 221–44.
14. Bergman Å, Heindel JJ, Jobling S, Kidd K, Zoeller TR, Organization WH. State of the science
of endocrine disrupting chemicals 2012. World Health Organization; 2013.
15. Chemicals U. Ridding the world of POPs: A guide to the Stockholm convention on persistent
organic pollutants, the secretariat of the Stockholm convention and UNEP’s information unit
for conventions. April; 2005.
16. Qing Li Q, Loganath A, Seng Chong Y, Tan J, Philip Obbard J. Persistent organic pollutants
and adverse health effects in humans. J Toxicol Environ Health. 2006;69(21):1987–2005.
17. Grün F, Blumberg B. Environmental obesogens: organotins and endocrine disruption via
nuclear receptor signaling. Endocrinology. 2006;147(6):s50–s5.
18. Köhrle J. Environment and endocrinology: the case of thyroidology. Ann Endocrinol.
2008;69(2):116–22.
19. Hofmann PJ, Schomburg L, Köhrle J. Interference of endocrine disrupters with thyroid hormone receptor–dependent transactivation. Toxicol Sci. 2009;110(1):125–37.
20. George M, Ramesh N, Gopal S, Mohan V, Fathima FN. Diabetes and hypertension--A comprehensive assessment among workers in selected tea plantations, South India. Int J Med Sci
Public Health. 2018;7(12):1005–11.
21. Pestana D, Faria G, Sá C, Fernandes VC, Teixeira D, Norberto S, et al. Persistent organic pollutant levels in human visceral and subcutaneous adipose tissue in obese individuals—Depot
differences and dysmetabolism implications. Environ Res. 2014;133:170–7.
22. Soriano S, Alonso-Magdalena P, García-Arévalo M, Novials A, Muhammed SJ, Salehi A,
et al. Rapid insulinotropic action of low doses of bisphenol-A on mouse and human islets of
Langerhans: role of estrogen receptor β. PLoS One. 2012;7(2):e31109.
23. Batista TM, Alonso-Magdalena P, Vieira E, Amaral MEC, Cederroth CR, Nef S, et al. Shortterm treatment with bisphenol-A leads to metabolic abnormalities in adult male mice. PLoS
One. 2012;7(3):e33814.
24. Gothai S, Ganesan P, Park S-Y, Fakurazi S, Choi D-K, Arulselvan PJN. Natural phytobioactive compounds for the treatment of type 2 diabetes: inflammation as a target. Nutrients.
2016;8(8):461.
25. McAnany B, Martirosyan D. The effects of bioactive compounds on Alzheimer’s disease and
mild cognitive impairment. Funct Foods Health Dis. 2016;6(6):329–43.
26. Granzotto A, Zatta P. Resveratrol and Alzheimer’s disease: message in a bottle on red wine and
cognition. Front Aging Neurosci. 2014;6:95.
27. Vetterli L, Brun T, Giovannoni L, Bosco D, Maechler P. Resveratrol potentiates glucosestimulated insulin secretion in INS-1E β-cells and human islets through a SIRT1-dependent
mechanism. J Biol Chem. 2011;286(8):6049–60.
28. Eid HM, Nachar A, Thong F, Sweeney G, Haddad PS. The molecular basis of the antidiabetic action of quercetin in cultured skeletal muscle cells and hepatocytes. Pharmacogn Mag.
2015;11(41):74.
29. Youl E, Bardy G, Magous R, Cros G, Sejalon F, Virsolvy A, et al. Quercetin potentiates insulin
secretion and protects INS-1 pancreatic β-cells against oxidative damage via the ERK1/2 pathway. Br J Pharmacol. 2010;161(4):799–814.
30. Peng J, Li Q, Li K, Zhu L, Lin X, Lin X, et al. Quercetin improves glucose and lipid metabolism
of diabetic rats: involvement of Akt signaling and SIRT1. J Diabetes Res. 2017;2017:3417306.
31. Nijveldt RJ, Van Nood E, Van Hoorn DE, Boelens PG, Van Norren K, Van Leeuwen
PA. Flavonoids: a review of probable mechanisms of action and potential applications. Am J
Clin Nutr. 2001;74(4):418–25.
32. Oh YS, Jun H-SJN. Role of bioactive food components in diabetes prevention: effects on Betacell function and preservation. Nutr Metab Insights. 2014;7:51–9.
T. H. Mallhi et al.